685 related articles for article (PubMed ID: 15545925)
1. Inhibition of toll-like receptor and cytokine signaling--a unifying theme in ischemic tolerance.
Karikó K; Weissman D; Welsh FA
J Cereb Blood Flow Metab; 2004 Nov; 24(11):1288-304. PubMed ID: 15545925
[TBL] [Abstract][Full Text] [Related]
2. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
3. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
Loppnow H; Werdan K; Buerke M
Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system.
Ozato K; Tsujimura H; Tamura T
Biotechniques; 2002 Oct; Suppl():66-8, 70, 72 passim. PubMed ID: 12395929
[TBL] [Abstract][Full Text] [Related]
5. Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR.
Mantovani A; Locati M; Polentarutti N; Vecchi A; Garlanda C
J Leukoc Biol; 2004 May; 75(5):738-42. PubMed ID: 14673019
[TBL] [Abstract][Full Text] [Related]
6. Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation?
Andreakos E; Foxwell B; Feldmann M
Immunol Rev; 2004 Dec; 202():250-65. PubMed ID: 15546398
[TBL] [Abstract][Full Text] [Related]
7. Regulation of innate immune responses by Toll-like receptors.
Takeda K; Akira S
Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
[TBL] [Abstract][Full Text] [Related]
8. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.
Roelofs MF; Joosten LA; Abdollahi-Roodsaz S; van Lieshout AW; Sprong T; van den Hoogen FH; van den Berg WB; Radstake TR
Arthritis Rheum; 2005 Aug; 52(8):2313-22. PubMed ID: 16052591
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system.
Netea MG; van der Graaf C; Van der Meer JW; Kullberg BJ
J Leukoc Biol; 2004 May; 75(5):749-55. PubMed ID: 15075354
[TBL] [Abstract][Full Text] [Related]
10. Modulating toll-like receptor signalling as a novel antiinfective approach.
Mbow ML; Sarisky RT
Drug News Perspect; 2005 Apr; 18(3):179-84. PubMed ID: 15915219
[TBL] [Abstract][Full Text] [Related]
11. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense.
Dunne A; O'Neill LA
Sci STKE; 2003 Feb; 2003(171):re3. PubMed ID: 12606705
[TBL] [Abstract][Full Text] [Related]
12. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis.
Mao TK; Lian ZX; Selmi C; Ichiki Y; Ashwood P; Ansari AA; Coppel RL; Shimoda S; Ishibashi H; Gershwin ME
Hepatology; 2005 Oct; 42(4):802-8. PubMed ID: 16175622
[TBL] [Abstract][Full Text] [Related]
13. Function and mechanism of toll-like receptors in cerebral ischemic tolerance: from preconditioning to treatment.
Wang PF; Xiong XY; Chen J; Wang YC; Duan W; Yang QW
J Neuroinflammation; 2015 Apr; 12():80. PubMed ID: 25928750
[TBL] [Abstract][Full Text] [Related]
14. IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures.
Vezzani A; Maroso M; Balosso S; Sanchez MA; Bartfai T
Brain Behav Immun; 2011 Oct; 25(7):1281-9. PubMed ID: 21473909
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory and neuroimmunomodulatory changes in acute cerebral ischemia.
Brea D; Sobrino T; Ramos-Cabrer P; Castillo J
Cerebrovasc Dis; 2009; 27 Suppl 1():48-64. PubMed ID: 19342833
[TBL] [Abstract][Full Text] [Related]
16. Evolution and integration of innate immune recognition systems: the Toll-like receptors.
Takeda K
J Endotoxin Res; 2005; 11(1):51-5. PubMed ID: 15826379
[TBL] [Abstract][Full Text] [Related]
17. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14.
Ellingsen E; Morath S; Flo T; Schromm A; Hartung T; Thiemermann C; Espevik T; Golenbock D; Foster D; Solberg R; Aasen A; Wang J
Med Sci Monit; 2002 May; 8(5):BR149-56. PubMed ID: 12011760
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
[TBL] [Abstract][Full Text] [Related]
19. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors.
Takaoka A; Yanai H; Kondo S; Duncan G; Negishi H; Mizutani T; Kano S; Honda K; Ohba Y; Mak TW; Taniguchi T
Nature; 2005 Mar; 434(7030):243-9. PubMed ID: 15665823
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptors in cerebral ischemic inflammatory injury.
Wang YC; Lin S; Yang QW
J Neuroinflammation; 2011 Oct; 8():134. PubMed ID: 21982558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
